The Potential Protective Role of GS-441524, a Metabolite of the Prodrug Remdesivir, in Vaccine Breakthrough SARS-CoV-2 Infections. (2022)
Attributed to:
Privacy and Attestation Technologies
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/978-3-642-27954-6_21
PubMed Identifier: 36407474
Publication URI: http://europepmc.org/abstract/MED/36407474
Type: Journal Article/Review
Volume: 2
Parent Publication: Intensive care research
Issue: 3-4
ISBN: 978-3-642-27953-9
ISSN: 2666-9862